The national fight over sugary soda is bubbling up in the San Francisco Bay Area, where voters in November will consider a tax on the drinks that many health experts say contribute to diabetes, obesity and tooth decay.
Senators are asking the Justice Department to investigate whether pharmaceutical company Mylan acted illegally when it classified its life-saving EpiPen as a generic drug and qualified for lower rebate payments to states.
Anheuser-Busch InBev will pay $6 million to settle charges by U.S. regulators that it paid off government officials in India to boost sales and production, then tried to quiet an employee who raised the issue.
An exit button inside a downtown Atlanta hotel where a worker was found dead failed to work during an inspection, trapping two people who had to beat on the door to alert someone to let them out, a medical examiner found.
A defensive Donald Trump gave Hillary Clinton plenty of fresh material for the next phase of her presidential campaign on Tuesday, choosing to publicly reopen and relitigate some her most damaging attacks.
The Senate acted decisively Wednesday to override President Barack Obama's veto of Sept. 11 legislation, setting the stage for the contentious bill to become law despite flaws that Obama and top Pentagon officials warn could put U.S. troops and interests at risk.